IMCnyeso

· Immunocore Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IMCnyeso, covering 2022-03-11 to 2022-03-11. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of IMCnyeso in Advanced NY-ESO-1 and/or LAGE-1A Positive Cancers [Phase 1, Phase 2]